Evidence map›Paper›PMID 31209406›Full record

ArticleNature immunology2019

Subsets of ILC3-ILC1-like cells generate a diversity spectrum of innate lymphoid cells in human mucosal tissues.

Marina Cella, Ramya Gamini, Cristiane Sécca, Patrick L Collins, Shanrong Zhao, Vincent Peng, Michelle L Robinette, Jorge Schettini, Konstantin Zaitsev, William Gordon and 14 more

Erratum issuedOpen access · greenAbstract read
In one paragraph

Article in Nature immunology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 129 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
129citing papers in PubMed, 1 pooled it
9.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

129 citing papers in PubMed, 1 synthesis or guideline pooled it, 190 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Resident CD49aScience advances · 2026
    Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Origin of Hypofunctional CD103European journal of immunology · 2025
    Article
  17. Article
  18. Article
  19. Article
  20. Article

69 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

24 authors at 8 institutions in 2 countries.

Marina CellaDepartment of Pathology and Immunology, Washington University School of Medicine, St Louis, MO, USA.ORCID http://orcid.org/0000-0003-1230-1313
Ramya GaminiPfizer Worldwide Research and Development, Cambridge, MA, USA.
Cristiane SéccaDepartment of Pathology and Immunology, Washington University School of Medicine, St Louis, MO, USA.ORCID http://orcid.org/0000-0003-4433-8962
Patrick L CollinsDepartment of Pathology and Immunology, Washington University School of Medicine, St Louis, MO, USA.
Shanrong ZhaoPfizer Worldwide Research and Development, Cambridge, MA, USA.
Vincent PengDepartment of Pathology and Immunology, Washington University School of Medicine, St Louis, MO, USA.
Michelle L RobinetteDepartment of Pathology and Immunology, Washington University School of Medicine, St Louis, MO, USA.ORCID http://orcid.org/0000-0003-0965-5225
Jorge SchettiniPfizer Worldwide Research and Development, Cambridge, MA, USA.
Konstantin ZaitsevDepartment of Pathology and Immunology, Washington University School of Medicine, St Louis, MO, USA.ORCID http://orcid.org/0000-0003-3749-0886
William GordonPfizer Worldwide Research and Development, Cambridge, MA, USA.
Jennifer K BandoDepartment of Pathology and Immunology, Washington University School of Medicine, St Louis, MO, USA.
Kentaro YomogidaDepartment of Pathology and Immunology, Washington University School of Medicine, St Louis, MO, USA.
Victor CortezDepartment of Pathology and Immunology, Washington University School of Medicine, St Louis, MO, USA.
Catrina FronickThe McDonnell Genome Institute, Washington University School of Medicine, St Louis, MO, USA.
Robert FultonThe McDonnell Genome Institute, Washington University School of Medicine, St Louis, MO, USA.
Lih-Ling LinPfizer Worldwide Research and Development, Cambridge, MA, USA.
Susan GilfillanDepartment of Pathology and Immunology, Washington University School of Medicine, St Louis, MO, USA.
Richard A FlavellDepartment of Immunobiology, Yale University School of Medicine, New Haven, CT, USA.ORCID http://orcid.org/0000-0003-4461-0778
Liang ShanDepartment of Medicine, Division of Infectious Diseases, Washington University School of Medicine, St Louis, MO, USA.
Maxim N ArtyomovDepartment of Pathology and Immunology, Washington University School of Medicine, St Louis, MO, USA.
Michael BowmanPfizer Worldwide Research and Development, Cambridge, MA, USA.
Eugene M OltzDepartment of Pathology and Immunology, Washington University School of Medicine, St Louis, MO, USA.
Scott A JelinskyPfizer Worldwide Research and Development, Cambridge, MA, USA. Scott.Jelinsky@pfizer.com.ORCID http://orcid.org/0000-0002-5114-0236
Marco ColonnaDepartment of Pathology and Immunology, Washington University School of Medicine, St Louis, MO, USA. mcolonna@wustl.edu.ORCID http://orcid.org/0000-0001-5222-4987
Washington University in St. Louis · USPfizer (United States) · USJames S. McDonnell Foundation · USBiogen (United States) · USBrigham and Women's Hospital · USHoward Hughes Medical Institute · USITMO University · RUUniversity of California, San Francisco · US

Funding

Washington University Center for Cellular ImagingP30CA091842 · NCI · WASHINGTON UNIVERSITY · PI TIMOTHY J. EBERLEIN · 2001 to 2026
$128.0M
Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
WU INSTITUTE OF CLINICAL AND TRANSLATIONAL SCIENCESUL1TR002345 · NCATS · WASHINGTON UNIVERSITY · PI William G. Powderly · 2017 to 2026
$97.8M
Washington University Institute of Clinical and Translational SciencesUL1TR000448 · NCATS · WASHINGTON UNIVERSITY · PI EVANOFF, BRADLEY A · 2012 to 2016
$41.4M
Transcriptomics and Repertoire ProfilingP01AI106697 · NIAID · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI Donna L. Farber · 2013 to 2026
$31.3M
Washington University DDRCC Supplemental Equipment RequestP30DK052574 · NIDDK · WASHINGTON UNIVERSITY · PI Nicholas O. Davidson · 2000 to 2026
$30.8M
Mucosal Immune Defense Mechanisms of the Urinary BladderU01AI095542 · NIAID · WASHINGTON UNIVERSITY · PI COLONNA, MARCO, HULTGREN, SCOTT J. · 2011 to 2020
$9.8M
Washington University Rheumatic DiseasesResearch Resource-based CenterP30AR073752 · NIAMS · WASHINGTON UNIVERSITY · PI Alfred Hyoungju Kim · 2018 to 2026
$7.6M
CIS-REGULATORY CIRCUITS FOR ILC FUNCTION AND PLASTICITYR01AI134035 · NIAID · WASHINGTON UNIVERSITY · PI MARCO COLONNA, Eugene M Oltz · 2018 to 2026
$4.8M
The role of TGFbeta in development and function of salivary gland innate lymphoid cellsR01DE025884 · NIDCR · WASHINGTON UNIVERSITY · PI COLONNA, MARCO, WEISMAN, GARY ANDREW · 2017 to 2021
$3.5M
SEQUENCE-SPECIFIC CHROMATIN MODIFIERS; NOVEL PROTEIN THERAPEUTICS FOR B CELL LYMPHOMAR01CA188286 · NCI · WASHINGTON UNIVERSITY · PI OLTZ, EUGENE M, PAYTON, JACQUELINE E. · 2015 to 2019
$1.7M
Immune Checkpoints for Intestinal Innate Lymphoid CellsK99DK118110 · NIDDK · WASHINGTON UNIVERSITY · PI BANDO, JENNIFER KAORU · 2019 to 2020
$182k
NCATS NIH HHS UL1 TR000448NCATS NIH HHS UL1 TR001863NCATS NIH HHS UL1 TR002345NCI NIH HHS P30 CA091842NCI NIH HHS R01 CA188286NIAID NIH HHS P01 AI106697NIAID NIH HHS R01 AI134035NIAID NIH HHS U01 AI095542NIAMS NIH HHS P30 AR073752NIDCR NIH HHS R01 DE025884NIDDK NIH HHS K99 DK118110NIDDK NIH HHS P30 DK052574
6 · The paper itself

Abstract

Innate lymphoid cells (ILCs) are tissue-resident lymphocytes categorized on the basis of their core regulatory programs and the expression of signature cytokines. Human ILC3s that produce the cytokine interleukin-22 convert into ILC1-like cells that produce interferon-γ in vitro, but whether this conversion occurs in vivo remains unclear. In the present study we found that ILC3s and ILC1s in human tonsils represented the ends of a spectrum that included additional discrete subsets. RNA velocity analysis identified an intermediate ILC3-ILC1 cluster, which had strong directionality toward ILC1s. In humanized mice, the acquisition of ILC1 features by ILC3s showed tissue dependency. Chromatin studies indicated that the transcription factors Aiolos and T-bet cooperated to repress regulatory elements active in ILC3s. A transitional ILC3-ILC1 population was also detected in the human intestine. We conclude that ILC3s undergo conversion into ILC1-like cells in human tissues in vivo, and that tissue factors and Aiolos were required for this process.

Indexed as

AnimalsCell DifferentiationCells, CulturedChildChild, PreschoolHumansIkaros Transcription FactorImmunity, InnateInterferon-gammaInterleukin-22InterleukinsIntestinal MucosaLymphocytesMicePalatine TonsilT-bet Transcription FactorIFNG protein, humanIkaros Transcription FactorIKZF3 protein, humanInterferon-gammaInterleukin-22InterleukinsT-bet Transcription FactorT-Box Domain Proteins

Identifiers

PMID31209406
PMCPMC6685551
OpenAlexW2952676054

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.